Connect with us

Technology

Enova Reports First Quarter 2025 Results

Published

on

Originations rose 26% and total company revenue increased 22% from the first quarter of 2024Diluted earnings per share of $2.69 increased 64% and adjusted earnings per share1 of $2.98 rose 56% compared to the first quarter of 2024Credit performance remained strong compared to a year ago with a stable net charge-off ratio of 8.6% and stable net revenue margin of 57%Year-over-year improvement in the consolidated 30+ day delinquency ratio of 7.7% and stability in the consolidated portfolio fair value premium of 115% reflect a stable credit outlookLiquidity, including cash and marketable securities and available capacity on facilities, totaled $1.1 billion at March 31Share repurchases during the quarter totaled $63 million

CHICAGO, April 29, 2025 /PRNewswire/ — Enova International (NYSE: ENVA), a leading financial services company powered by machine learning and world-class analytics, today announced financial results for the first quarter ended March 31, 2025. 

“We are pleased to deliver another quarter of strong financial results,” said David Fisher, Enova’s CEO. “Solid demand and stable credit across our products reflect the continued strength of our consumer and small business customers, who are benefitting from a strong labor market, wage growth and retail spending. While there has been recent volatility in the financial markets and questions about the direction of the economy, we are confident that our balanced growth strategy along with our diversified products, flexible online-only model, world-class risk management and technology and experienced team will allow us to adapt quickly to the operating environment to deliver profitable growth while effectively managing risk.”

First Quarter 2025 Summary

Total revenue of $746 million increased 22% from $610 million in the first quarter of 2024.Net revenue margin of 57% is consistent with the first quarter of 2024, reflecting continued solid credit performance.Net income of $73 million, or $2.69 per diluted share, increased 51% from $48 million, or $1.64 per diluted share, in the first quarter of 2024.Adjusted EBITDA1 of $190 million increased 27% from $149 million in the first quarter of 2024.Adjusted earnings per share1 of $2.98 increased 56% from $1.91 per diluted share in the first quarter of 2024.Total company combined loans and finance receivables1 increased 20% from the end of the first quarter of 2024 to a record $4.1 billion with total company originations of $1.7 billion in the quarter.Repurchased $63 million of common stock under the company’s share repurchase program.

“We delivered another quarter of solid top- and bottom-line results that exceeded our expectations,” said Steve Cunningham, CFO of Enova. “Our strong financial performance in the first quarter continues to demonstrate how the powerful combination of our diversified product offerings, scalable operating model, world-class risk management capabilities and balance sheet flexibility allow us to consistently deliver strong results.  We remain well positioned to successfully navigate a range of operating environments while delivering on our commitment to drive long term shareholder value through both continued investments in our business and opportunistic share repurchases.”

1 Non-GAAP measure. Refer to “Non-GAAP Financial Measures,” “Loans and Finance Receivables Financial and Operating Data,” and “Reconciliation of GAAP to Non-GAAP Financial Measures” below for additional information.

Conference Call

Enova will host a conference call to discuss its first quarter 2025 results at 4 p.m. Central Time / 5 p.m. Eastern Time today, April 29th. The live webcast of the call can be accessed at the Enova Investor Relations website at http://ir.enova.com, along with the company’s earnings press release and supplemental financial information. The U.S. dial-in for the call is 1-855-560-2575 (1-412-542-4161 for non-U.S. callers). Please ask to join the Enova International call. A replay of the conference call will be available until May 6, 2025, at 10:59 p.m. Central Time / 11:59 p.m. Eastern Time, while an archived version of the webcast will be available on the Enova International Investor Relations website for 90 days. The U.S. dial-in for the conference call replay is 1-877-344-7529 (1-412-317-0088). The replay access code is 9725416.

About Enova

Enova International (NYSE: ENVA) is a leading online financial services company that serves small businesses and consumers who are underserved by traditional banks. Over its 20-year history, Enova has provided over $61 billion in loans and financing to more than 12 million customers by offering a suite of market-leading products powered by the company’s world-class analytics, machine learning algorithms and proprietary technology. You can learn more about the company and its portfolio of businesses at www.enova.com.

Cautionary Statement Concerning Forward Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 about the business, financial condition and prospects of Enova. These forward-looking statements give current expectations or forecasts of future events and reflect the views and assumptions of Enova’s senior management with respect to the business, financial condition and prospects of Enova as of the date of this release and are not guarantees of future performance. The actual results of Enova could differ materially from those indicated by such forward-looking statements because of various risks and uncertainties applicable to Enova’s business, including, without limitation, those risks and uncertainties indicated in Enova’s filings with the Securities and Exchange Commission (“SEC”), including our annual report on Form 10-K, quarterly reports on Forms 10-Q and current reports on Forms 8-K. These risks and uncertainties are beyond the ability of Enova to control, and, in many cases, Enova cannot predict all of the risks and uncertainties that could cause its actual results to differ materially from those indicated by the forward-looking statements. When used in this release, the words “believes,” “estimates,” “plans,” “expects,” “anticipates” and similar expressions or variations as they relate to Enova or its management are intended to identify forward-looking statements. Enova cautions you not to put undue reliance on these statements. Enova disclaims any intention or obligation to update or revise any forward-looking statements after the date of this release.

Non-GAAP Financial Measures

In addition to the financial information prepared in conformity with generally accepted accounting principles in the United States, or GAAP, Enova provides historical non-GAAP financial information. Enova presents non-GAAP financial information because such measures are used by management in understanding the activities and business metrics of Enova’s operations. Management believes that these non-GAAP financial measures reflect an additional way of viewing aspects of Enova’s business that, when viewed with its GAAP results, provide a more complete understanding of factors and trends affecting its business.

Management provides non-GAAP financial information for informational purposes and to enhance understanding of Enova’s GAAP consolidated financial statements. Readers should consider the information in addition to, but not instead of or superior to, Enova’s financial statements prepared in accordance with GAAP. This non-GAAP financial information may be determined or calculated differently by other companies, limiting the usefulness of those measures for comparative purposes.

Combined Loans and Finance Receivables
The combined loans and finance receivables measures are non-GAAP measures that include loans and finance receivables that Enova owns or has purchased and loans that Enova guarantees. Management believes these non-GAAP measures provide management and investors with important information needed to evaluate the magnitude of potential receivable losses and the opportunity for revenue performance of the loans and finance receivable portfolio on an aggregate basis. Management also believes that the comparison of the aggregate amounts from period to period is more meaningful than comparing only the amounts reflected on Enova’s consolidated balance sheet since revenue is impacted by the aggregate amount of receivables owned by Enova and those guaranteed by Enova as reflected in its consolidated financial statements.

Adjusted Earnings Measures
Enova provides adjusted earnings and adjusted earnings per share, or, collectively, the Adjusted Earnings Measures, which are non-GAAP measures. Management believes that the presentation of these measures provides investors with greater transparency and facilitates comparison of operating results across a broad spectrum of companies with varying capital structures, compensation strategies, derivative instruments and amortization methods, which can provide a more complete understanding of Enova’s financial performance, competitive position and prospects for the future. Management utilizes, and also believes that investors utilize, the Adjusted Earnings Measures to assess operating performance, recognizing that such measures may highlight trends in Enova’s business that may not otherwise be apparent when relying on financial measures calculated in accordance with GAAP. In addition, management believes that the Adjusted Earnings Measures are useful to management and investors in comparing Enova’s financial results during the periods shown without the effect of certain items that are not indicative of Enova’s core operating performance or results of operations.

Adjusted EBITDA Measures
Enova provides Adjusted EBITDA and Adjusted EBITDA margin, or, collectively, the Adjusted EBITDA measures, which are non-GAAP measures. Adjusted EBITDA is a non-GAAP measure that Enova defines as earnings excluding depreciation, amortization, interest, foreign currency transaction gains or losses, taxes, stock-based compensation and certain other items, as appropriate, that are not indicative of our core operating performance. Adjusted EBITDA margin is a non-GAAP measure that Enova defines as Adjusted EBITDA as a percentage of total revenue. Management utilizes, and also believes that investors utilize, Adjusted EBITDA Measures to analyze operating performance and evaluate Enova’s ability to incur and service debt and Enova’s capacity for making capital expenditures. Enova believes that Adjusted EBITDA is useful to management and investors in comparing Enova’s financial results during the periods shown without the effect of certain non-cash items and certain items that are not indicative of Enova’s core operating performance or results of operations. Adjusted EBITDA Measures are also useful to investors to help assess Enova’s estimated enterprise value.

ENOVA INTERNATIONAL, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(dollars in thousands, except per share data)

(Unaudited)

March 31,

December 31,

2025

2024

2024

Assets

Cash and cash equivalents

$

55,514

$

76,458

$

73,910

Restricted cash

256,342

152,469

248,758

Loans and finance receivables at fair value

4,569,819

3,795,210

4,386,444

Income taxes receivable

48,117

85,424

40,690

Other receivables and prepaid expenses

71,617

65,963

63,752

Property and equipment, net

124,791

111,678

119,956

Operating lease right-of-use assets

17,607

13,651

18,201

Goodwill

279,275

279,275

279,275

Intangible assets, net

8,937

16,991

10,951

Other assets

25,239

39,408

24,194

Total assets

$

5,457,258

$

4,636,527

$

5,266,131

Liabilities and Stockholders’ Equity

Accounts payable and accrued expenses

$

237,420

$

290,603

$

249,970

Operating lease liabilities

32,144

26,959

32,165

Deferred tax liabilities, net

233,693

127,887

223,590

Long-term debt

3,757,351

3,040,867

3,563,482

Total liabilities

4,260,608

3,486,316

4,069,207

Commitments and contingencies

Stockholders’ equity:

Common stock, $0.00001 par value, 250,000,000 shares authorized,
47,085,738, 46,193,337 and 46,520,916 shares issued and 25,559,390,
27,349,818 and 25,808,096 outstanding as of March 31, 2025 and
2024 and December 31, 2024, respectively

Preferred stock, $0.00001 par value, 25,000,000 shares authorized, no
shares issued and outstanding

Additional paid in capital

337,679

298,191

328,268

Retained earnings

1,770,699

1,536,734

1,697,754

Accumulated other comprehensive loss

(10,782)

(7,234)

(13,691)

Treasury stock, at cost (21,526,348, 18,843,519 and 20,712,820
shares as of March 31, 2025 and 2024 and December 31, 2024, respectively)

(900,946)

(677,480)

(815,407)

Total stockholders’ equity

1,196,650

1,150,211

1,196,924

Total liabilities and stockholders’ equity

$

5,457,258

$

4,636,527

$

5,266,131

 

ENOVA INTERNATIONAL, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(in thousands, except per share data)

(Unaudited)

Three Months Ended

March 31,

2025

2024

Revenue

$

745,541

$

609,889

Change in Fair Value

(319,359)

(264,023)

Net Revenue

426,182

345,866

Operating Expenses

Marketing

139,291

110,567

Operations and technology

62,462

54,379

General and administrative

42,464

39,865

Depreciation and amortization

10,061

10,263

Total Operating Expenses

254,278

215,074

Income from Operations

171,904

130,792

Interest expense, net

(80,544)

(65,597)

Foreign currency transaction loss

(452)

(48)

Equity method investment gain

120

Other nonoperating expenses

(492)

Income before Income Taxes

91,028

64,655

Provision for income taxes

18,083

16,227

Net income

$

72,945

$

48,428

Earnings Per Share

Earnings per common share:

Basic

$

2.84

$

1.72

Diluted

$

2.69

$

1.64

Weighted average common shares outstanding:

Basic

25,676

28,196

Diluted

27,104

29,503

 

ENOVA INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(dollars in thousands)

(Unaudited)

Three Months Ended March 31,

2025

2024

Total cash flows provided by operating activities

$

391,144

$

348,563

Cash flows from investing activities

Loans and finance receivables

(496,715)

(431,959)

Capitalization of software development costs and purchases of fixed assets

(12,875)

(11,225)

Total cash flows used in investing activities

(509,590)

(443,184)

Cash flows provided by (used in) financing activities

107,327

(53,975)

Effect of exchange rates on cash, cash equivalents and restricted cash

307

84

Net (decrease) increase in cash, cash equivalents and restricted cash

(10,812)

148,512

Cash, cash equivalents and restricted cash at beginning of year

322,668

377,439

Cash, cash equivalents and restricted cash at end of period

$

311,856

$

228,927

 

ENOVA INTERNATIONAL, INC. AND SUBSIDIARIES
LOANS AND FINANCE RECEIVABLES FINANCIAL AND OPERATING DATA
(dollars in thousands)

The following table includes financial information for loans and finance receivables, which is based on loan and finance receivable balances for the three months ended March 31, 2025 and 2024.

Three Months Ended March 31,

2025

2024

Change

Ending combined loan and finance receivable principal balance:

Company owned

$

3,964,419

$

3,298,430

$

665,989

Guaranteed by the Company(a)

14,813

10,780

4,033

Total combined loan and finance receivable principal balance(b)

$

3,979,232

$

3,309,210

$

670,022

Ending combined loan and finance receivable fair value balance:

Company owned

$

4,569,819

$

3,795,210

$

774,609

Guaranteed by the Company(a)

21,225

14,773

6,452

Ending combined loan and finance receivable fair value balance(b)

$

4,591,044

$

3,809,983

$

781,061

Fair value as a % of principal(c)

115.4

%

115.1

%

0.3

%

Ending combined loan and finance receivable balance, including principal
and accrued fees/interest outstanding:

Company owned

$

4,117,245

$

3,438,468

$

678,777

Guaranteed by the Company(a)

17,954

13,046

4,908

Ending combined loan and finance receivable balance(b)

$

4,135,199

$

3,451,514

$

683,685

Average combined loan and finance receivable balance, including
principal and accrued fees/interest outstanding:

Company owned(d)

$

4,068,475

$

3,376,099

$

692,376

Guaranteed by the Company(a)(d)

20,700

14,956

5,744

Average combined loan and finance receivable balance(a)(d)

$

4,089,175

$

3,391,055

$

698,120

Installment loans as percentage of average combined loan and finance
receivable balance

44.4

%

48.9

%

(4.5)

%

Line of credit accounts as percentage of average combined loan and
finance receivable balance

55.6

%

51.1

%

4.5

%

Revenue

$

735,421

$

601,208

$

134,213

Change in fair value

(317,480)

(262,106)

(55,374)

Net revenue

$

417,941

$

339,102

$

78,839

Net revenue margin

56.8

%

56.4

%

0.4

%

Combined loan and finance receivable originations and purchases

$

1,729,479

$

1,377,367

$

352,112

Delinquencies:

>30 days delinquent

$

318,356

$

279,659

$

38,697

>30 days delinquent as a % of combined loan and finance receivable balance(c)

7.7

%

8.1

%

(0.4)

%

Charge-offs:

Charge-offs (net of recoveries)

$

350,336

$

286,698

$

63,638

Charge-offs (net of recoveries) as a % of average combined loan and
finance receivable balance(d)

8.6

%

8.5

%

0.1

%

(a)

Represents loans originated by third-party lenders through the CSO programs, which are not included in our consolidated balance sheets.

(b)

Non-GAAP measure.

(c)

Determined using period-end balances.

(d)

The average combined loan and finance receivable balance is the average of the month-end balances during the period.

 

ENOVA INTERNATIONAL, INC. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

(dollars in thousands, except per share data)

Adjusted Earnings Measures

Three Months Ended

March 31,

2025

2024

Net income

$

72,945

$

48,428

Adjustments:

Transaction-related costs(a)

327

Equity method investment gain

(120)

Other nonoperating expenses(b)

492

Intangible asset amortization

2,014

2,014

Stock-based compensation expense

7,936

7,639

Foreign currency transaction loss

452

48

Cumulative tax effect of adjustments

(2,488)

(2,642)

Adjusted earnings

$

80,739

$

56,306

Diluted earnings per share

$

2.69

$

1.64

Adjusted earnings per share

$

2.98

$

1.91

Adjusted EBITDA

Three Months Ended

March 31,

2025

2024

Net income

$

72,945

$

48,428

Depreciation and amortization expenses

10,061

10,263

Interest expense, net

80,544

65,597

Foreign currency transaction loss

452

48

Provision for income taxes

18,083

16,227

Stock-based compensation expense

7,936

7,639

Adjustments:

Transaction-related costs(a)

327

Equity method investment gain

(120)

Other nonoperating expenses(b)

492

Adjusted EBITDA

$

189,901

$

149,021

Adjusted EBITDA margin calculated as follows:

Total Revenue

$

745,541

$

609,889

Adjusted EBITDA

189,901

149,021

Adjusted EBITDA as a percentage of total revenue

25.5

%

24.4

%

(a)

In the first quarter of 2024, the Company recorded $0.3 million ($0.2 million net of tax) of costs related to a consent solicitation for the Senior Notes due 2025.

(b)

In the first quarter of 2024, the Company recorded other nonoperating expense of $0.5 million ($0.4 million net of tax) related to the repurchase of senior notes.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/enova-reports-first-quarter-2025-results-302441601.html

SOURCE Enova International, Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

SUNGLASS HUT CELEBRATES “OWN YOUR MOMENT” & COVENT GARDEN POP-UP WITH AN UNFORGETTABLE LONDON EVENT FRONTED BY AMBASSADOR MELANIE C

Published

on

By

LONDON, June 2, 2026 /PRNewswire/ — Sunglass Hut, the leading global destination for premium sunglasses, brought its OWN YOUR MOMENT summer campaign to life with an exclusive event to launch its consumer pop-up in London’s Covent Garden. The evening celebrated the brand’s summer collection alongside global ambassador Melanie C, delivering a high-energy experience for consumers to enjoy.

The night was kicked off by Sunglass Hut ambassador and Spice Girl Melanie C, who took to the decks for a special DJ set, setting the tone for an evening that was equal parts fashion and fun. Guests explored the collection, enjoyed the atmosphere and embraced the spirit of the campaign, centred on confidence, individuality and living in the moment.

Guests enjoyed a series of thoughtfully curated experiences throughout the evening. Bespoke goody bags offered guests a keepsake from the campaign and artisan gelato from Badiani brought a refined touch of Italian flair.

At the heart of the event was the opportunity to explore the summer collection first-hand, including key seasonal styles from Ray-Ban, Oakley and Ray-Ban Meta, alongside a broader mix of leading fashion brands and Sunglass Hut exclusives. Guests were also able to browse Melanie C’s dedicated product edit, a curation of easy everyday styles with a sporty edge and elevated designer pieces, available on Sunglass Hut ecommerce and in select stores.

The pop-up is part of a wider summer ambassador series in which Sunglass Hut is deepening local relevance through authentic talent partnerships and bold customer experiences. Melanie C joins Breanna Stewart in the United States and María Pedraza in Spain as part of the brand’s global summer ambassador series, each hosting an event inspired by the culture and energy of their market.

The Sunglass Hut pop-up is now open to the public at Covent Garden, running until 14th June, 12pm-7pm daily.

First introduced in 2025, OWN YOUR MOMENT marked a refreshed brand positioning for Sunglass Hut, creating a more inspiring and emotionally resonant identity for customers around the world. The platform celebrates the idea that sunglasses are more than an accessory. They have the power to transform how people see the world and how the world sees them.

Shop the summer collection and Melanie C’s edit now at: www.sunglasshut.com

About Sunglass Hut

Founded in 1971, Sunglass Hut has grown into the best curated destination for the most sought-after high-quality fashion and performance sunglass brands, with more than 2,500 retail locations. Stores can be found in fashionable shopping districts across the globe, from the Americas, Europe and the Middle East to Australia, South Africa, China, Southeast Asia and beyond, providing consumers with a fun, highly engaging shopping experience in-store and online. www.sunglasshut.com 

About EssilorLuxottica

EssilorLuxottica is a global leader in the design, manufacturing, and distribution of ophthalmic lenses, frames, and sunglasses. With more than 200,000 employees across 150 countries, 650 operational facilities and 18,000 stores, its mission is to help people around the world see more and be more by addressing their evolving vision needs and personal style aspirations.

EssilorLuxottica is home to some of the most advanced lens technologies, including Varilux, Stellest, and Transitions, as well as some of the most iconic eyewear brands, including Ray-Ban and Oakley, highly sought-after licensed luxury brands, and world-class retailers such as Sunglass Hut, Óticas Carol, and GrandVision.

The OneSight EssilorLuxottica Foundation has enabled access to sustainable vision care for more than 760 million people in underserved communities worldwide. For more information, visit www.essilorluxottica.com

Photo – https://mma.prnewswire.com/media/2993703/Sunglass_Hut.jpg

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/sunglass-hut-celebrates-own-your-moment–covent-garden-pop-up-with-an-unforgettable-london-event-fronted-by-ambassador-melanie-c-302789301.html

Continue Reading

Technology

HIMSS and SingHealth to Co-Host 2026 HIMSS APAC Health Conference & Exhibition in Singapore to Accelerate Healthcare Transformation

Published

on

By

SINGAPORE, June 3, 2026 /PRNewswire/ — HIMSS, a mission-driven independent society, global thought leader and advisor, will co-host the 2026 HIMSS APAC Health Conference & Exhibition 23–25 August 2026 in Singapore in strategic partnership with SingHealth, Singapore’s largest public group of healthcare institutions.

HIMSS26 APAC will convene senior health system leaders, government ministers, clinicians and technology innovators from across Asia-Pacific and beyond to address the defining challenge of the time: translating AI ambition into scalable, evidence-based impact.

Under the theme “Trust, Intelligence and Agility: Re-engineering APAC Health Systems in the AI Era,” the three-day program will combine an exclusive pre-conference CXO AI Summit, two days of main conference plenary and parallel tracks, an exhibition, curated hospital visits and executive networking to create an unparalleled environment for peer exchange, strategic insight and high-value connections.

“Health systems across Asia-Pacific have focused ambition and investment in the deployment of AI tools and capabilities. The global challenge is translating momentum into scalable, system-wide impact,” said Hal Wolf, HIMSS President and CEO. “HIMSS26 APAC will bring together leaders, frameworks and real-world evidence to guide health systems through measurable transformation. We are proud to develop this program in close partnership with our APAC Steering committee, comprised of senior healthcare executives and digital health leaders from APAC markets, to deliver the best insights at the conference.”

A Strategic Partnership with SingHealth

HIMSS26 APAC is co-hosted with SingHealth, Singapore’s largest public healthcare cluster. The partnership reflects Singapore’s position as the APAC hub for digital health innovation. Additionally, this partnership connects HIMSS26 APAC delegates directly to the team leading Singapore’s national health data strategy, AI governance frameworks and digital maturity programs.

Benedict Tan, Group Chief Digital Strategy Officer and Chief Data Officer at SingHealth and Board Member of HIMSS, will deliver keynotes at both the CXO AI Summit and the main conference opening ceremony. This reflects SingHealth’s commitment to inspire other healthcare systems to use AI with trust, transparency and measurable impact.

Three Days of High-Stakes Dialogue

The programme is built around the questions that matter most to health system leaders right now: Is AI ROI the wrong metric? What does a smart hospital look like in the age of AI? And what separates the systems that are scaling innovation from those still experimenting?

The conference opens on 23 August with an invitation-only CXO AI Summit, an executive forum challenging the conventional wisdom on AI return on investment, governance and the foundations of enterprise-scale adoption. The Summit will be anchored by keynotes from Hal Wolf and Benedict Tan, with panel discussions moderated by Dr Anne Snowdon, Chief Scientific Officer of HIMSS, and Tom Leary, HIMSS Senior Vice President and Head of Government Relations. International speakers from health systems from across the Asia-Pacific region will be announced soon.

The main conference on 24–25 August opens with a showcase of excellence in digital maturity before moving into two days of plenary keynotes, executive addresses, government perspectives from across APAC and deep-dive parallel tracks spanning AI digital foundation, clinical AI, operational AI and smart hospitals and intelligent health systems. Senior perspectives from health ministries and leading digital health organisations across South Korea, Australia, Singapore and the broader Asia-Pacific region will be featured throughout.

The programme closes with a cross-industry panel asking what healthcare can learn from other sectors already reshaped by AI, bringing together voices from health technology, clinical leadership and beyond.

Members of the press, potential media partners and podcasters interested in participating in HIMSS26 APAC are invited to email the HIMSS Communications team at press@himss.org for more information.

About HIMSS

HIMSS (the Healthcare Information and Management Systems Society) is a mission-driven independent society, a global thought leader, and an advisor dedicated to creating an informed and empowered community of providers, innovators, and individuals. HIMSS stands apart by bridging strategic and visionary ideas with practical execution, empowering health systems and governments globally to achieve measurable impact for the future of health and care.

About SingHealth

SingHealth is Singapore’s largest group of healthcare institutions, comprising an integrated network of hospitals, specialty centres, and polyclinics committed to providing quality, accessible healthcare. As a regional leader in integrated digital health, SingHealth serves as both co-host and a real-world model of how policy, infrastructure, and innovation align to support system-wide transformation.

 

View original content:https://www.prnewswire.com/apac/news-releases/himss-and-singhealth-to-co-host-2026-himss-apac-health-conference–exhibition-in-singapore-to-accelerate-healthcare-transformation-302789309.html

SOURCE HIMSS-HEALTHCARE INFORMATION AND MANAGEMENT SYSTEMS SOCIETY

Continue Reading

Technology

NAVC Named to Inc.’s 2026 Best Workplaces List

Published

on

By

Annual list recognizes the businesses that set the standard for workplace success and awards excellence in company culture

ORLANDO, Fla., June 2, 2026 /PRNewswire/ — NAVC has been named one of Inc.’s 2026 Best Workplaces. This annual award honors American companies with exceptional workplaces and vibrant cultures that support their teams and businesses, whether in-person, remote or hybrid.

“A happy team is a high-performing one, and at NAVC, we believe in creating environments where everyone can thrive,” said Gene O’Neill, NAVC CEO. “Our culture is centered on the team, which naturally unlocks potential. We host open forums where employees share ideas and feedback, and we prioritize investing in professional development for all staff. The result? An incredible group of passionate and talented individuals. NAVC is a special place to work for one reason – the people.”

Who is NAVC?

NAVC is a nonprofit organization with a mission to support and advance veterinary professionals across the globe. As the leading provider of veterinary continuing education, NAVC delivers essential training and resources that keep the veterinary community informed of the latest advances in animal medicine. NAVC’s diverse portfolio of products and services includes:

In-person and virtual educational events like VMX, HiVE, SkillShop and LevelUPVetfolio – a robust virtual learning platformEducational podcastsFour award-winning, peer-reviewed publicationsAdvocacy work in the animal health space

Best Workplaces Award Methodology

The award is the result of a comprehensive measurement and evaluation of hundreds of applicants. The process involved a detailed employee survey conducted by Quantum Workplace, covering critical elements such as management effectiveness, perks, professional development and overall company culture. Each company’s benefits were also audited to determine the overall score. NAVC is honored to be included among the 507 companies recognized this year.

“This year’s Best Workplaces list goes beyond great company culture–it highlights companies making meaningful and sustained investment in their employees,” says Bonny Ghosh, editorial director at Inc. “Even in a labor market that favors employers, these companies understand that an intentional and authentic commitment to their teams drives stronger employee retention, engagement, and ultimately, a stronger business overall.”

To view the full list of winners, visit Inc.com.

About NAVC

The North American Veterinary Community (NAVC) is a nonprofit organization dedicated to supporting and advancing veterinary professionals worldwide. The world’s leading provider of veterinary continuing education, the NAVC delivers essential training, tools and resources for veterinary professionals to stay abreast of advances in animal medicine and provide the best medical care for animals everywhere. Through its commitment to innovation and excellence, the NAVC has developed a diverse portfolio of products and services, including: educational events, headlined by VMX, the world’s largest, most comprehensive continuing education conference and launchpad for new products and innovations within the veterinary industry; a robust digital platform for virtual learning and engagement; the veterinary industry’s largest and award-winning portfolio of trade publications; and an advocacy arm which unites the veterinary community and pet lovers. The NAVC was founded in 1982 and is headquartered in Orlando, FL. Since 2017, the NAVC has been recognized annually as one of the Top Workplaces by the Orlando Sentinel. To learn more about the NAVC’s products and brands, visit https://navc.com/. To see our schedule of upcoming events, visit https://navc.com/calendar/.

About Inc.

Inc. is the leading media brand and playbook for entrepreneurs and business. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit www.inc.com.

About Quantum Workplace

Quantum Workplace, based in Omaha, Nebraska, is an HR technology company that serves organizations through employee-engagement surveys, action-planning tools, exit surveys, peer-to-peer recognition, performance evaluations, goal tracking, and leadership assessment. For more information, visit QuantumWorkplace.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/navc-named-to-incs-2026-best-workplaces-list-302789324.html

SOURCE North American Veterinary Community (NAVC)

Continue Reading

Trending